GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » YoY EBITDA Growth

AprilBio Co (XKRX:397030) YoY EBITDA Growth : 161.77% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AprilBio Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 161.77%.

AprilBio Co's EBITDA per Share for the three months ended in Mar. 2025 was ₩42.06.

AprilBio Co YoY EBITDA Growth Historical Data

The historical data trend for AprilBio Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co YoY EBITDA Growth Chart

AprilBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 54.09 -140.79 85.82 -37.70 272.13

AprilBio Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.36 1,797.20 -87.43 219.85 161.77

AprilBio Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AprilBio Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(1010.076--586.797)/ | -586.797 |
=272.13 %

AprilBio Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(42.061--68.088)/ | -68.088 |
=161.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AprilBio Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AprilBio Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

AprilBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:389650 XKRX:475960 XKRX:228760 XKRX:334970 XKRX:078160 XKRX:064550 XKRX:372320 XKRX:011000 XKRX:140610 XKRX:115180 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1 Kangwon National University Road, B-602, College of Medical and Life Sciences, Kangwon National University, Gangwon Special Self-Governing Province, Chuncheon-si, KOR
Website
http://www.aprilbio.com
AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co Headlines

No Headlines